Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
RECURSION PHARMACEUTICALS, INC. | Chief Medical Officer | Class A Common Stock | 121K | $1.28M | $10.58 | May 16, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RXRX | RECURSION PHARMACEUTICALS, INC. | May 16, 2022 | 1 | -$4.72K | 4 | May 18, 2022 | Chief Medical Officer |
RXRX | RECURSION PHARMACEUTICALS, INC. | Mar 31, 2022 | 2 | $22.5K | 4 | Apr 4, 2022 | Chief Medical Officer |
RXRX | RECURSION PHARMACEUTICALS, INC. | Feb 28, 2022 | 2 | $38.8K | 4 | Mar 1, 2022 | Chief Medical Officer |
RXRX | RECURSION PHARMACEUTICALS, INC. | Feb 4, 2022 | 5 | -$11.2K | 4 | Feb 8, 2022 | Chief Medical Officer |
RXRX | RECURSION PHARMACEUTICALS, INC. | Jan 31, 2022 | 2 | $38.8K | 4 | Feb 2, 2022 | Chief Medical Officer |
RXRX | RECURSION PHARMACEUTICALS, INC. | Jan 3, 2022 | 2 | $99.6K | 4 | Jan 5, 2022 | Chief Medical Officer |